LANXESS AG UNSP.ADR 1/5 (LX9B) - Total Liabilities
Based on the latest financial reports, LANXESS AG UNSP.ADR 1/5 (LX9B) has total liabilities worth €4.28 Billion EUR (≈ $5.00 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is LANXESS AG UNSP.ADR 1/5 growing its equity to track the company's year-over-year net asset growth rate.
LANXESS AG UNSP.ADR 1/5 - Total Liabilities Trend (2021–2024)
This chart illustrates how LANXESS AG UNSP.ADR 1/5's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of LANXESS AG UNSP.ADR 1/5 to measure how efficiently the company converts operating cash flow to free cash.
LANXESS AG UNSP.ADR 1/5 Competitors by Total Liabilities
The table below lists competitors of LANXESS AG UNSP.ADR 1/5 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dynapack International Technology
TWO:3211
|
Taiwan | NT$5.62 Billion |
|
BBMG Corp Class A
SHG:601992
|
China | CN¥174.70 Billion |
|
African Rainbow Minerals Ltd
JSE:ARI
|
South Africa | ZAC14.20 Billion |
|
Australian United Investment Company Ltd
AU:AUI
|
Australia | AU$399.22 Million |
|
Ruentex Industries Ltd
TW:2915
|
Taiwan | NT$13.26 Billion |
|
Atlas Energy Solutions Inc.
NYSE:AESI
|
USA | $1.13 Billion |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321
|
China | CN¥1.98 Billion |
|
Bob's Discount Furniture, Inc.
NYSE:BOBS
|
USA | $815.06 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down LANXESS AG UNSP.ADR 1/5's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of LANXESS AG UNSP.ADR 1/5.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.10 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how LANXESS AG UNSP.ADR 1/5's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for LANXESS AG UNSP.ADR 1/5 (2021–2024)
The table below shows the annual total liabilities of LANXESS AG UNSP.ADR 1/5 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €5.12 Billion ≈ $5.98 Billion |
-0.76% |
| 2023-12-31 | €5.16 Billion ≈ $6.03 Billion |
-24.81% |
| 2022-12-31 | €6.86 Billion ≈ $8.02 Billion |
+1.39% |
| 2021-12-31 | €6.77 Billion ≈ $7.91 Billion |
-- |
About LANXESS AG UNSP.ADR 1/5
LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative soluti… Read more